Listening in on bacterial conversations could be the solution for improving chronic wound care, says a team of researchers at Binghamton University, State University of New York. Their findings have been published in the Journal of Applied Microbiology.
"Bacteria, often viewed as simplistic creatures, are in fact very sociable units of life," said Alex Rickard, assistant professor of biological sciences. "They can physically and chemically interact with one another and are quite selective about who they hang out with. How bacteria might communicate in chronic wounds, however, was somewhat of a mystery."
Working with researchers and physicians at the Center for Biofilm Engineering at Montana State University and the South West Regional Wound Care Center in Lubbock, Texas, Rickard and a team of undergraduate researchers were able to identify specific types of chronic wound bacteria and to test their ability to produce cell-cell signaling molecules.
Partial gene sequencing allowed the team to identify 46 chronic wound strains belonging to nine genera. Further research inferred that close to 70 percent of those chronic wound strains produce a specific type of communication molecule – autoinducer-2 (AI-2). A smaller percentage – around 20 percent – produce a different type of communication molecules that are called acyl-homoserine-lactones (AHLs). Scientists already know that structurally different bacterial cell-cell signaling molecules are able to mediate cell-cell communication, including A1-2 and AHLs.
"Based on our findings, we think that most resident species – the 'good' bacteria that live on us and don't cause disease – produce AI-2 while the pathogenic species typically produce AHLs," said Katelynn Manton, who was part of the undergraduate team and is now pursuing her doctorate. "And it didn't seem to matter what kind of chronic wound we looked at – diabetic ulcers, vascular ulcers or environmentally induced chronic wounds. They all indicated a presence of possible AHLs or AI-2s."
For Randy Wolcott, director of the Southwest Regional Wound Care Center, a clearer understanding of how these bacteria function is particularly important. "AI-2s may be the best explanation why our commensal coagulase negative Staphylococci and other synergistically helpful bacteria are immensely beneficial to us when they reside in a normal skin environment," he said. "However, when they turn or are coerced to a dark side in a wound or infected medical device, they can cause so much devastation and death."
According to Rickard and his team, the typically pathogenic bacteria communicate in one language, the 'good' bacteria in another. The big question now is whether any of them are bilingual and can listen in on one another's 'conversations.' Being able to interpret – or perhaps even guide – these cell-cell signals may be important factors in how wound development could be influenced.
"Can we steer pathogenic bacteria away from what is, in essence, a 'mob' mentality and prevent them from communicating," said Rickard. "Or can we tell the mob to do one thing when they should in fact be doing something completely different?"
Manipulation of cell-cell signaling has the potential to be an effective strategy for wound healing, particularly in influencing 'bad' bacteria –which are particularly resistant to antimicrobials. Typical chronic wound bacteria such as Pseudomonas aeruginosa tend to have an entire repertoire of aggressive tactics that allow them to maintain a strong presence in chronic wounds. As a result, they are able to multiply rapidly, driving out the resident species and hampering wound healing.
"When bacteria form biofilms, as they do in chronic wounds, they become protected from killing by antimicrobial agents," said Phil Stewart, director of the Center for Biofilm Engineering at Montana State University. "Topical antiseptics, systemic antibiotics, and the body's own defenses are unable to clear these infections. We need alternative strategies – such as jamming bacterial communication – to help weaken the biofilm defenses. Listening in on the bacterial signals may also provide a way to diagnose the state of a chronic wound."
Funded by two grants from the National Institutes of Health, Rickard is hoping to expand the study.
"I have been very fortunate to have access to a terrific range of top-notch undergraduate researchers here at Binghamton University," said Rickard. "And I will be tapping in to this resource yet again when we tackle the next phase of this project. Our goal is to include a wider range of wound types and compare the types of signals present. By doing this, we expect to be able to develop novel methods to monitor wound healing and ultimately prevent the establishment of chronic wounds."
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.